FDA approves a new oral treatment for MS

This popped up in my emails & I wanted to post about it here.

The FDA has approved Mavenclad tablets to treat relapsing forms of MS in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically isolated syndrome. Because of it's safety profile, the use of Mavenclad is generally recommended for patients who had an inadequate response to, or are unable to tolerate, an alternate drug indicated for treatment of MS.

To read about this medication it instructed people to read at Mavenclad.com.